Inspire Medical Systems I... (INSP)
NYSE: INSP
· Real-Time Price · USD
149.54
-6.28 (-4.03%)
At close: May 15, 2025, 3:59 PM
149.01
-0.35%
After-hours: May 15, 2025, 04:09 PM EDT
Company Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Inspire Medical Systems Inc.

Country | United States |
IPO Date | May 3, 2018 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 1,246 |
CEO | Timothy P. Herbert |
Contact Details
Address: 5500 Wayzata Boulevard Golden Valley, Minnesota United States | |
Website | https://www.inspiresleep.com |
Stock Details
Ticker Symbol | INSP |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001609550 |
CUSIP Number | 457730109 |
ISIN Number | US4577301090 |
Employer ID | 26-1377674 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Timothy P. Herbert | Founder, Chairman, Chief Executive Officer & President |
Richard J. Buchholz | Chief Financial Officer |
Andreas Henke | Executive Vice President & MD of Europe |
Bryan K. Phillips J.D. | Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary |
Carlton W. Weatherby | Chief Strategy and Growth Officer |
Ivan Lubogo | SVice President of Strategic Sales |
Jason P. Kelly | Chief Manufacturing & Quality Officer |
Joe Sander | SVice President U.S. Sales |
Megan Rowekamp CPA | Director of Financial Reporting |
Randall A. Ban | EVice President of Patient Access &Therapy Development |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 13, 2025 | SCHEDULE 13G | Filing |
May 05, 2025 | 4 | Filing |
May 05, 2025 | 4 | Filing |
May 05, 2025 | 4 | Filing |
May 05, 2025 | 4 | Filing |
May 05, 2025 | 4 | Filing |
May 05, 2025 | 4 | Filing |
May 05, 2025 | 4 | Filing |
May 05, 2025 | 4 | Filing |
May 05, 2025 | 10-Q | Quarterly Report |